About

DCAT Value Chain Insights

DCAT Value Chain Insights and its companion newsletter, Top Industry News, are online information resources offering:

  • Original in-depth analysis on the issues impacting the business of biopharmaceutical/pharmaceutical development and manufacturing
  • Targeted and timely news stories focusing on the issues directly affecting professionals involved in the biopharmaceutical/pharmaceutical manufacturing value chain
  • A weekly electronic newsletter delivering readers the latest need-to-know information to help them keep pace with a dynamic marketplace

DCAT Value Chain Insights content can be found on this dedicated website and is also available directly to subscribers and DCAT member company contacts in an e-newsletter format each Wednesday.

Have questions on how to contribute editorially? Contact Patricia Van Arnum, DCAT’s Editorial Director, at This email address is being protected from spambots. You need JavaScript enabled to view it., Tele: +1.609.208.1888 Ext 7014

Scope of Coverage

DCAT Value Chain Insights covers the full spectrum of the biopharmaceutical/pharmaceutical manufacturing value chain from raw materials to intermediates to drug substances (small molecules and biologics) to drug products (solid dosage, parenterals, and specialty dosage forms) to packaging and the related supply chains.

Audience

C-suite, senior to mid-level executives from innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Functional areas of readers include:

  • Sourcing, procurement, supply management, and external manufacturing
  • Business development, sales, and marketing
  • Manufacturing and quality in support of the above functions

Subscribe

DCAT Value Chain Insights: A weekly electronic edition of DCAT Value Chain Insights is delivered each Wednesday to subscribers. Click here to subscribe.

PLUS, Top Industry News: To help DCAT members never miss the most important developments impacting the global biopharmaceutical/pharmaceutical industry and its manufacturing value chain, DCAT delivers each Friday, Top Industry News, the top news stories of the week as selected by DCAT's Editorial Director Patricia Van Arnum. Click here to subscribe.

Drug, Chemical & Associated Technologies Association (DCAT)

The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies.

The DCAT organization is committed to provide programs, events and services that help its members:

  • Meet their business objectives
  • Expand their network of customers and suppliers
  • Gain insight into industry trends, markets, and those issues impacting biopharmaceutical/pharmaceutical development and manufacturing

Learn more about the DCAT organization.

Editorial Team

Patricia Van Arnum, Editorial Director

This email address is being protected from spambots. You need JavaScript enabled to view it.

Patricia Van Arnum is Editorial Director at the Drug, Chemical & Associated Technologies Association (DCAT), where she is responsible for delivering informational services for DCAT members She is editor of two weekly editorial newsletters, DCAT Value Chain Insights and Top Industry News.

She also supports DCAT’s volunteer committees and task forces that develop educational programs and informational content for DCAT members: the Education Committee and its task forces for DCAT Week education programs and the Supply Management Committee for Sharp Sourcing and other informational content.

Overall, she has more than 25 years of experience covering the pharmaceutical, biopharmaceutical, and fine-chemical industries as a business and science editor. She is a member of the American Chemical Society, the American Association of Pharmaceutical Scientists, and the American Association for the Advancement of Science and holds undergraduate degrees in chemistry, economics, and political science.

Editorial Committee

The Value Chain Insights Editorial Committee is responsible for advising DCAT staff on topics and subjects of interest to DCAT members for DCAT Value Chain Insights, a weekly information resource of DCAT, and for offering feedback on its editorial content. The breadth and depth of the collective expertise of members of the Value Chain Insights Editorial Committee ensures that DCAT Value Chain Insights serves the varying information needs of DCAT member companies and that it delivers topical, salient, and relevant content for DCAT members.

The Committee members are:

  • Kelsey Achenbach, Head of Marketing, Pharmaceuticals, Roquette
  • Michael Cannarsa, PhD, Director, Business Development, Almac Sciences
  • Desiree Quizon-Colquitt,Senior Manager, CRD-Global External Supply, Pfizer
  • Deborah A. Davis, PhD, Senior Director, Process R&D, AbbVie, and Committee Chair
  • Claus Feussner, PhD, Senior Vice President, Vetter Development Service
  • Dr. Stephan Fleck, CEO, Rottendorf Pharma GmbH & Rottendorf Pharma, Inc.
  • Amy Schmidt, National Director, Sales, Nosco
  • DCAT Staff Liaisons: Patricia Van Arnum, Editorial Director and Erin Sanders, Senior Communications & Technology Specialist